Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • blancha
    Senior Member
    • May 2013
    • 367

    Alignment on hg19 or hg38 for exome-seq data

    Hi,

    I've just received the sequencing results from 6 exome-seq experiments.
    The samples come from human patients.

    Would you recommend aligning the samples on hg19 or hg38?
    Have you all switched to hg38, or do you still use hg19?
    Is hg19 still better annotated, and does it still have more related datasets facilitating downstream analyses?

    I will launch the alignment based on your recommendations.

    Sorry if the answer is obvious.
    I haven't done any exome-seq analyses since the release of hg38.

    Thank
  • vivek_
    PhD Student
    • Jul 2012
    • 164

    #2
    I still stick with hg19 mainly because I annotate variants with population allele frequencies and 1000 genomes/ExAC datasets still use hg19 the last I checked. However Once UCSC releases the annotation, you can safely start using the new genome build.

    Comment

    • blancha
      Senior Member
      • May 2013
      • 367

      #3
      That's a good point.

      The 1000 Genomes Project actually has a post on their twitter feed stating that they are recruiting a developer to move the data to GRCh38.
      We are hiring a new developer to help maintain the data, moving the data to GRCh38 and drawing in new data types https://t.co/i8TzT5W5vJ


      On the other hand, the updates to GRCh38 are based partly on the 1000 Genomes project, so it's ironic not to move on because the 1000 Genomes Project hasn't moved on yet.
      "Sequence updates - Several erroneous bases and misassembled regions in GRCh37 have been corrected in the GRCh38 assembly, and more than 100 gaps have been filled or reduced. Much of the data used to improve the reference sequence was obtained from other genome sequencing and analysis projects, such as the 1000 Genomes Project."


      I understand from my discussions with other analysts that hg19 is still used by the overwhelming majority of bioinformaticians, even though the official announcements about hg38 tout all its improvements.

      If anyone is using hg38 for exome-seq data, I'be interested to hear about your experience.
      For example, is it simple to use liftover to compare to earlier datasets aligned with hg19, e.g. the 1000 Genomes project?

      Comment

      • id0
        Senior Member
        • Sep 2012
        • 130

        #4
        Most of the improvements are in the non-coding regions, so if you are doing exomes, you won't notice a difference.

        My concern would be future-proofing. If these are your first exomes, you may as well use hg38. If you need to use some hg19-based datasets, you can always liftover them to hg38. The problem is if you choose hg19 now and continue with that, you'll have to make a transition a couple of years down the road. It'll be a lot harder once you have a bunch of accumulated results.

        On the other hand, I still see a lot of people using mm9 and mm10 has been out since 2011.

        Comment

        • blancha
          Senior Member
          • May 2013
          • 367

          #5
          Well, I ended up trying to run concurrently the analyses on hg19 and hg38.
          I quickly gave up on the hg38 analysis.
          As vivek_ has warned me, the fact that the 1000 Genomes project is aligned on hg19 is a problem.
          I was unable to follow the GATK DNASeq Best Practices with hg38 given that there are no VCF files available for hg38 identifying known indels and SNPs.

          I think the switch to hg38 will be effortless once the 1000 Genomes Project has transitioned to hg38. I'll stick to hg19 untill that transition has been completed.

          I'll have to tell the researcher I gave up on doing the analysis with hg38. Hopefully id0 is right, and it will have no impact on the results.

          Comment

          • Richard Finney
            Senior Member
            • Feb 2009
            • 701

            #6
            How reliable would it be to lift over 1000 genome snps to GRCh38/hg38 ?

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 12:17 PM
            0 responses
            11 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            11 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            37 views
            0 reactions
            Last Post SEQadmin2  
            Working...